Schiff Hardin Advises Altaris in Pending Acquisition of 3M’s Drug Delivery Business

News

Schiff Hardin Advises Altaris in Pending Acquisition of 3M’s Drug Delivery Business

News Release |

Schiff Hardin LLP is representing an affiliate of Altaris Capital Partners LLC, a private investment firm focused on the healthcare industry, in its approximately $650 million pending acquisition of substantially all of 3M Company’s drug delivery business. As part of the transaction, 3M Company will retain a minority interest in the new business. The deal is expected to close in the first half of 2020.